Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Psoriasis

Discussion in 'General Issues and Discussion Forum' started by NewsBot, Oct 8, 2008.

Tags:
  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Medscape has these two new articles on emerging treatments and paradigms for the management of psoriasis (free registration required to access):
    Psoriasis Is a Systemic Disease: An Expert Interview With Alan Menter, MD
    New Treatment Paradigms for Psoriasis
     
  2. Admin2

    Admin2 Administrator Staff Member

  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release
    FDA Approves New Drug to Treat Psoriasis
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Successful treatment of hand and foot psoriasis with infliximab.
    Di Lernia V, Guareschi E.
    Dermatol Online J. 2010 Jul 15;16(7):8.
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial.
    Leonardi C, Langley RG, Papp K, Tyring SK, Wasel N, Vender R, Unnebrink K, Gupta SR, Valdecantos WC, Bagel J.
    Arch Dermatol. 2011 Apr;147(4):429-36.
     
  6. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    PUBLIC RELEASE: 2-FEB-2017
    Treatment has no sufficient effect in 1 of 5 psoriasis patients
     
  7. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    FDA News Release
    FDA approves new psoriasis drug
    February 15, 2017
     
Loading...

Share This Page